← Back to Clinical Trials
Recruiting NCT06751056

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

Trial Parameters

Condition Pruritus
Sponsor Mayo Clinic
Study Type INTERVENTIONAL
Phase N/A
Enrollment 12
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-06-01
Completion 2027-01-10
Interventions
Cervical Traction Device

Brief Summary

The purpose of this study is to determine if cervical traction is an effective treatment to reduce GABAergic medication use for scalp, arm, and upper back neuropathic itch.

Eligibility Criteria

Inclusion Criteria * Persons with scalp, arm, and upper back pruritus without primary skin lesions. * Persons 18 or older. * Person on a stable dosage of gabapentin or pregabalin over the preceding 4 week period. * Persons willing and able to comply with clinic visits and study-related procedures. * Persons willing and able to understand and complete study-related questionnaires. * Persons willing and able to provide voluntary signed informed consent. Exclusion Criteria * Primary skin lesions driving scalp, arm, or upper back pruritus. * A history of spinal surgery or other conditions (acute or traumatic spinal injury, spinal instability, spinal fracture, rheumatoid arthritis, metastatic disease to the spine, spinal cord compression, active infections of the head and neck) that would make neck traction contraindicated. * Unable to comfortably lay down on the floor and get back up without assistance. * Medical conditions in which gabapentin and/or pregabalin is contraindicated. * Curren

Related Trials